Skip to content

Comparison of Pain Cervical Dilation Using Traditional Mechanical Dilators versus Hysteroscopic Cervical Morcellation in Office-Based Operative Hysteroscopy in Menopausal Women: A Randomized Controlled Trial

Comparison of Pain Cervical Dilation Using Traditional Mechanical Dilators versus Hysteroscopic Cervical Morcellation in Office-Based Operative Hysteroscopy in Menopausal Women: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260525001
Enrollment
56
Registered
2026-05-25
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postmenopausal women Abnormal uterine bleeding Intrauterine lesion Cervical stenosis Office hysteroscopy Cervical dilation Hysteroscopic tissue removal system Mechanical dilator Postmenopause Pain Cervical stenosis Operative hysteroscopy Randomized controlled trial

Interventions

Participants in this group will undergo cervical dilation using a hysteroscopic tissue removal system during office-based operative hysteroscopy. The procedure will be performed under direct hysterosc
Experimental Device,Active Comparator Device
Hysteroscopic Tissue Removal System,Hegar Dilator

Sponsors

Faculty of Medicine Ramathibodi Hospital, Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Postmenopausal women, defined as women with amenorrhea for 12 consecutive months, undergoing office-based operative hysteroscopy at the Gynecologic Outpatient Department, Ramathibodi Hospital, with indications for office hysteroscopy including: 1.1 Endometrial polyp 1.2 Intrauterine lesion not exceeding 2 centimeters in size 1.3 Abnormal endometrium requiring endometrial biopsy for diagnosis 2. History of vaginal delivery 3. No previous cervical surgery 4. No previous pelvic radiation 5. Able to communicate and assess pain during and after the procedure 6. Willing to participate and provide written informed consent 7. No prior use of vaginal estrogen within 3 months before the procedure

Exclusion criteria

Exclusion criteria: 1. Requirement for operative hysteroscopy under general anesthesia 2. Contraindications to hysteroscopy, including active pelvic or genital tract infection at the time of the procedure, suspected cervical cancer, or advanced endometrial cancer 3. Assessed by the attending physician as unsuitable for office-based operative hysteroscopy, including patients with severe anxiety or medical conditions inappropriate for outpatient hysteroscopy 4. Inability to undergo diagnostic hysteroscopy from the beginning of the procedure 5. No intrauterine pathology identified after hysteroscopy requiring operative hysteroscopy 6. No requirement for cervical dilation after hysteroscopic evaluation

Design outcomes

Primary

MeasureTime frame
Pain score During cervical dilation procedure Visual Analog scale (0-10)

Secondary

MeasureTime frame
Pain score during procedure Visual Analog scale (0-10),Pain score 15 minutes after procedure Visual Analog scale (0-10),Time time to access uterine cavity minutes,Time total procedure time minutes,Successful cervical dilation with access to uterine cavity During procedure Successful passage of the hysteroscope into the uterine cavity

Countries

Thailand

Contacts

Public ContactMananya Angkaew

Department of Obstetrics and Gynecology, Faculty of Medicine Ramathibodi Hospital, Mahidol University

mananyaang@gmail.com0819185516

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026